MENU
RGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Repligen (RGEN) Earnings Date & Reports

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

RGEN is expected to report earnings to rise 12.22% to 41 cents per share on November 04

Repligen RGEN Stock Earnings Reports
Q3'25
Est.
$0.42
Q2'25
Missed
by $0.02
Q1'25
Beat
by $0.04
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.10
The last earnings report on July 29 showed earnings per share of 37 cents, missing the estimate of 38 cents. With 832.02K shares outstanding, the current market capitalization sits at 10.26B.
View a ticker or compare two or three
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. RGEN showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of biologic drugs

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
41 Seyon Street
Phone
+1 781 250-0111
Employees
1783
Web
https://www.repligen.com